TASER Reports 2016 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
TASER Int'l (TASR) Another Quarter Of Camera Losses - Oppenheimer
May 5, 2016 7:30 AM EDTBookings showed the value proposition of TASER's (NASDAQ: TASR) product portfolio ($44.7M, +17% sequentially) but this was another quarter of mounting losses in the Axon/evidence.com segment, Oppenheimer analyst Andrew Uerkwitz said. Revenue beat Street estimates because of a $6M CEW deal... More
TASER Int'l (TASR) Tops Q1 EPS by 3c
May 4, 2016 4:11 PM EDTTASER Int'l (NASDAQ: TASR) reported Q1 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $55.5 million versus the consensus estimate of $51.82 million.
"We are off to a strong start in 2016 with double-digit Weapons growth, record Axon and... More
